The primary clinical scenario for which we envisage the IVM achieving clinical utility for T1DM patients (Fig 1) is a conceptual extension of the experiments described in this report–namely, implantation in diabetic patients to facilitate the very rapid uptake of regular insulin. Here, INS is linked to type 1 diabetes mellitus.